Trexquant Investment’s Alder Biopharmaceuticals ALDR Stock Holding History

Trexquant Investment’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-19,637	Closed	-$231K	–	1237
2019 Q2	$231K	Buy	+19,637	New	+$238K	0.02%	659
2019 Q1	–	Sell	-17,345	Closed	-$178K	–	1463
2018 Q4	$178K	Buy	+17,345	New	+$222K	0.01%	938
2017 Q2	–	Sell	-12,726	Closed	-$265K	–	1339
2017 Q1	$265K	Buy	+12,726	New	+$282K	0.03%	821
2016 Q1	–	Sell	-10,191	Closed	-$337K	–	1286
2015 Q4	$337K	Sell	10,191 -42,990	-81%	-$1.45M	0.03%	809
2015 Q3	$1.74M	Buy	53,181 +43,181	+432%	+$1.84M	0.15%	204
2015 Q2	$529K	Sell	10,000 -18,300	-65%	-$666K	0.06%	591
2015 Q1	$816K	Buy	+28,300	New	+$777K	0.08%	470

Other funds holding ALDR

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return